• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2022 - 2024年中国HIV非职业性暴露后预防诊所就诊者的服务利用和药物依从性分析

Analysis of Service Utilization and Medication Adherence Among Attendees of HIV Nonoccupational Post-Exposure Prophylaxis Clinics - China, 2022-2024.

作者信息

Tan Mengnan, Xu Jie, Dong Wei

机构信息

National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

出版信息

China CDC Wkly. 2025 Aug 22;7(34):1099-1105. doi: 10.46234/ccdcw2025.185.

DOI:10.46234/ccdcw2025.185
PMID:40936791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12421423/
Abstract

INTRODUCTION

Human Immunodeficiency Virus (HIV) nonoccupational post-exposure prophylaxis (nPEP) clinics are specialized healthcare facilities that provide urgent medical interventions to individuals with potential high-risk HIV exposures. This study analyzed utilization patterns of HIV nPEP services in China and examined factors associated with medication adherence among consultees, providing evidence to inform further implementation and optimization of HIV nPEP interventions.

METHODS

We analyzed nPEP case data collected from the national nPEP data information system between November 1, 2022, and November 1, 2024, using SPSS 29.0 software. Chi-square tests were applied to analyze characteristics of nPEP consultees, and logistic regression models were used to identify factors influencing medication adherence and follow-up compliance among those who initiated treatment.

RESULTS

As of November 1, 2024, 924 nPEP clinics nationwide received 54,108 consultees, with 53,405 (98.70%) initiating medication. Most individuals seeking services were male (88.63%), classified as high-risk (83.11%), and heterosexual with multiple partners (67.66%). The "BIC/FTC/TAF" regimen was selected by 63.07% of recipients. Nearly all users (99.03%) completed medication evaluation within 72 hours post-exposure. Among medication users, 60.34% (30,650) adhered to the full 28-day regimen, and 60.10% (30,509) completed either one-month or three-month follow-ups. Multivariate logistic regression analysis identified gender, exposure risk assessment results, exposure population classification, individual preferences, and medication regimen as significant factors influencing both 28-day medication adherence and follow-up compliance (<0.05).

CONCLUSIONS

nPEP clinic consultees in China are predominantly young male heterosexual individuals with multiple sexual partners, with most selecting the Biktarvy regimen. However, both current 28-day medication adherence and follow-up compliance rates remain suboptimal. High-risk men and those receiving the Biktarvy regimen demonstrate superior medication adherence and follow-up compliance compared to other groups. Further research is needed to develop targeted interventions to improve medication adherence and follow-up rates among nPEP recipients. Enhancing adherence and follow-up should be prioritized in future interventions, supported by continuous monitoring to inform timely intervention strategy adjustments.

摘要

引言

人类免疫缺陷病毒(HIV)非职业性暴露后预防(nPEP)诊所是专门的医疗机构,为有潜在高风险HIV暴露的个体提供紧急医疗干预。本研究分析了中国HIV nPEP服务的利用模式,并调查了咨询者中与药物依从性相关的因素,为进一步实施和优化HIV nPEP干预措施提供依据。

方法

我们使用SPSS 29.0软件分析了2022年11月1日至2024年11月1日期间从国家nPEP数据信息系统收集的nPEP病例数据。采用卡方检验分析nPEP咨询者的特征,并使用逻辑回归模型确定影响开始治疗者药物依从性和随访依从性的因素。

结果

截至2024年11月1日,全国924家nPEP诊所接待了54108名咨询者,其中53405人(98.70%)开始用药。寻求服务的大多数个体为男性(88.63%),属于高风险人群(83.11%),且为有多个性伴侣的异性恋者(67.66%)。63.07%的接受者选择了“比克恩丙诺片/恩曲他滨替诺福韦片”(BIC/FTC/TAF)方案。几乎所有使用者(99.03%)在暴露后72小时内完成了用药评估。在用药者中,60.34%(30650人)坚持完成了整个28天疗程,60.10%(30509人)完成了1个月或3个月的随访。多因素逻辑回归分析确定性别、暴露风险评估结果、暴露人群分类、个人偏好和用药方案是影响28天药物依从性和随访依从性的重要因素(<0.05)。

结论

中国nPEP诊所的咨询者主要是有多个性伴侣的年轻男性异性恋者,大多数选择比克恩丙诺片方案。然而,目前28天的药物依从率和随访依从率仍不理想。与其他组相比,高风险男性和接受比克恩丙诺片方案的人群表现出更好的药物依从性和随访依从性。需要进一步研究制定针对性干预措施,以提高nPEP接受者的药物依从性和随访率。在未来的干预中应优先提高依从性和随访率,并通过持续监测为及时调整干预策略提供支持。

相似文献

1
Analysis of Service Utilization and Medication Adherence Among Attendees of HIV Nonoccupational Post-Exposure Prophylaxis Clinics - China, 2022-2024.2022 - 2024年中国HIV非职业性暴露后预防诊所就诊者的服务利用和药物依从性分析
China CDC Wkly. 2025 Aug 22;7(34):1099-1105. doi: 10.46234/ccdcw2025.185.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study.多替拉韦转换期间HIV-1病毒载量抑制和耐药模式:一项基于人群的纵向研究
medRxiv. 2025 Sep 2:2025.09.01.25334862. doi: 10.1101/2025.09.01.25334862.
4
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
5
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.职业性HIV暴露后的抗逆转录病毒暴露后预防(PEP)。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3.
6
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.
7
Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV - CDC Recommendations, United States, 2025.2025年美国疾病控制与预防中心关于性接触、注射吸毒或其他非职业性接触HIV后抗逆转录病毒暴露后预防的建议
MMWR Recomm Rep. 2025 May 8;74(1):1-56. doi: 10.15585/mmwr.rr7401a1.
8
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2001(2):CD001220. doi: 10.1002/14651858.CD001220.
9
Post-pandemic planning for maternity care for local, regional, and national maternity systems across the four nations: a mixed-methods study.针对四个地区的地方、区域和国家孕产妇保健系统的疫情后规划:一项混合方法研究。
Health Soc Care Deliv Res. 2025 Sep;13(35):1-25. doi: 10.3310/HHTE6611.
10
The Role of Centralized Sexual Assault Care Centers in HIV Post-Exposure Prophylaxis Treatment Adherence: A Retrospective Single Center Analysis.集中式性侵犯护理中心在艾滋病病毒暴露后预防治疗依从性中的作用:一项回顾性单中心分析
Infect Dis Rep. 2025 Jul 3;17(4):77. doi: 10.3390/idr17040077.

本文引用的文献

1
Preliminary evaluation of a gamified smartphone intervention (O2O-PEP) for enhancing HIV post-exposure prophylaxis uptake in men who have sex with men: pilot feasibility study.一项用于提高男男性行为者艾滋病毒暴露后预防措施使用率的游戏化智能手机干预措施(线上到线下暴露后预防)的初步评估:试点可行性研究
BMC Public Health. 2025 Apr 25;25(1):1539. doi: 10.1186/s12889-025-22818-w.
2
Impact of Peer Referral on Pre-Exposure Prophylaxis Adherence and Persistence Among Men Who Have Sex with Men: A Cohort Study in China.同伴推荐对男男性行为者暴露前预防依从性和持续性的影响:一项中国队列研究
AIDS Behav. 2025 Jun;29(6):1831-1840. doi: 10.1007/s10461-025-04651-9. Epub 2025 Feb 10.
3
A global review of national guidelines of post-exposure prophylaxis for the prevention of HIV.全球预防艾滋病毒暴露后预防国家指南综述。
J Int AIDS Soc. 2025 Jan;28(1):e26333. doi: 10.1002/jia2.26333.
4
Understanding the Uptake and Outcomes of Non-occupational Postexposure Prophylaxis Use Through an Online Medical Platform in China: Web-Based Cross-sectional Study.理解中国在线医疗平台中非职业暴露后预防用药的使用情况和结果:基于网络的横断面研究。
J Med Internet Res. 2023 May 19;25:e42729. doi: 10.2196/42729.
5
An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1.一项评估比克替拉韦/恩曲他滨/丙酚替诺福韦复方制剂用于潜在人类免疫缺陷病毒 1 暴露后预防的开放性标签安全性和耐受性的研究。
Chin Med J (Engl). 2022 Nov 20;135(22):2725-2729. doi: 10.1097/CM9.0000000000002494.
6
Co-creation using crowdsourcing to promote PrEP adherence in China: study protocol for a stepped-wedge randomized controlled trial.使用众包进行共同创作以促进中国人群 PrEP 依从性的研究方案:一项阶梯式随机对照试验。
BMC Public Health. 2022 Sep 7;22(1):1697. doi: 10.1186/s12889-022-14117-5.
7
Implementation of HIV non-occupational post-exposure prophylaxis for men who have sex with men in 2 cities of Southwestern China.中国西南 2 城市男男性行为者 HIV 非职业暴露后预防实施情况
Medicine (Baltimore). 2021 Oct 29;100(43):e27563. doi: 10.1097/MD.0000000000027563.
8
A Pilot Program of Pre-Exposure and Post-Exposure Prophylaxis Promotion among Men Who Have Sex with Men - 7 Study Sites, China, 2018-2019.一项针对男男性行为者的暴露前和暴露后预防推广试点项目——中国7个研究地点,2018 - 2019年
China CDC Wkly. 2020 Nov 27;2(48):917-919. doi: 10.46234/ccdcw2020.250.
9
HIV post-exposure prophylaxis (PEP).艾滋病病毒暴露后预防(PEP)。
BMJ. 2018 Nov 29;363:k4928. doi: 10.1136/bmj.k4928.
10
Adherence to HIV post-exposure prophylaxis: A multivariate regression analysis of a 5 years prospective cohort.HIV 暴露后预防用药依从性:一项 5 年前瞻性队列的多变量回归分析。
J Infect. 2018 Jan;76(1):78-85. doi: 10.1016/j.jinf.2017.10.008. Epub 2017 Oct 23.